CA2327169A1 - Solid phase test for endotoxin - Google Patents

Solid phase test for endotoxin Download PDF

Info

Publication number
CA2327169A1
CA2327169A1 CA002327169A CA2327169A CA2327169A1 CA 2327169 A1 CA2327169 A1 CA 2327169A1 CA 002327169 A CA002327169 A CA 002327169A CA 2327169 A CA2327169 A CA 2327169A CA 2327169 A1 CA2327169 A1 CA 2327169A1
Authority
CA
Canada
Prior art keywords
endotoxin
solid phase
phase apparatus
indicator
liquid sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002327169A
Other languages
French (fr)
Inventor
Arezki Mahiout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allied Therapeutics Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2327169A1 publication Critical patent/CA2327169A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/579Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving limulus lysate
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/32Assays involving biological materials from specific organisms or of a specific nature from bacteria from Bacillus (G)
    • G01N2333/325Bacillus thuringiensis crystal protein (delta-endotoxin)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

A solid phase apparatus, for detection of endotoxin in a liquid sample using reagents located within solid support material, comprises endotoxin sensitive reagent and buffer components. When a liquid sample containing endotoxin is applied to the apparatus the endotoxin sensitive reagent reacts with the endotoxin to form at least one product, and following contact of the at least one product with buffer components, an endotoxin indicator is formed. Also disclosed are a method and a kit to test for endotoxin.

Description

10-JGr-GKJrJYJ LO~Gl I'IHIfITJ 6 JhlUlKt i'JGIO -ftiJb YJI~I'Jl h'.1~~1~J1~

wo ms332~ rcrrcs9sro~o99 S()L1D PHASE TEST FOR ~NDOTOXIN
" This invention relates to a solid phase test for endotoxin, in particular.a test such as in a flat sheet or in capillary form for the detection of endotoxin in aqueous solutions. More particularly the invention relates to a direct solid phase chromogenic assay, which permits a quick biochemical identification of endotoxin and is sensitive to pico~3ram endotoxin~amounts.
There is a high demand for testing for contamination of solutions and biological fluids in medicine and iriotechnologies; for instance, the quality of water used for the dilution of solute concentrates for hemodialysis. Specifically, there is a need for pyrogen free water to make dialysate, and far monitoring of the dialysate in the dialysis machine itself in centres or at home or other non-laboratory settings. (n this respect, the production of sterile and pyrogen free dialysate needs a pyrogen control method which will give a 'yes" or "contaminated" result. Endotoxin,~ a potent pyrogen specifically from gram-negative bacterial cell wall components, is one of the mast known key contaminants. Measurements of endotoxin are today used as the major safe-y parameter of infusions and fluids in general, drugs and devices, in the pharma:ology and food industry.. The most available method to qualitatively and quanti-:atively detect endotoxin in biological or aqueous solutions is based on the limulus amoebocyte lysate (LAL) test known in the art.
The LAL test was dis~:overed in 196ø by Levin and Bang' . Horseshoe crab (limulus) amoebocyte lysate provokes together with endotoxin from gram-negative bacteria a gelatination induced by a stepwise activation of several coagulation factors contained in tile lysate. An assay comprising the extract (lysate) of horseshoe crab blood cell (amoebocyte) to induce this ge(atination in a reagent glass as a liquid phasE system is welt known as a method and it is called the limulus test. The application of the LAL to measure endvtoxin involves the gelatination of the sample (gelation method, turbidimetry assay) in the reagent glass or a more sen;,itive method based on a chromogenic substrate and measurement by optics absorption. Today different LAL from horseshoe crab I
are SUBSTrTUT>w SHEET (RUE~E 26) sa-5tr-~t~ m: ~~ MH I HY5 7S ShIU 1 Kt d'~I~ ~rase dem r. tai WD 99153322 , PCT1GB991Q1099 commercialized through the world: Limulus Polyplfemus, Tchypleus tridendatrrs, Tachypleus gigas and Carcinoscorpius rotundicauda.
r.' Al! commercialized LAL testing methods based on a chromogenic substrate are liquid-phase assays. Th~. principle is that in a reagent glass containing a lysate and sample, bacterial sndo~toxin contained in the sample initiates activation of a cascade of serine protease (Factor 8, Factor C, Proclotting enzyme, Coagulin) enzymes in LAL that cl~:ave the end product coagulogen into a peptide coagulin which produces clotting. The use of a synthetic chromogenic or fluorogenic substrate increases the sensitivity of the testing and makes the quantification of endotoxin possible. As described by Iwanaga et al', a synthetic peptide is used having an amino acid sequence in common with the hydrolysis sites of coagulogen, namely the chromogenic substrate Boc-Leu-Gly-Arg-p-nitraanilide IpNA~ or the fluoro-genie substrate Box-Leu-Gly-Arg-4-methylcoumaryf-7-amide. !n the presence of LAL and endotoxin, the colourless substrate is rapidly cleaved to form the chromophore p-nitroaniline or the fiuorogenic 4-methylcoumaryl-7-amide.
There are today increasing improvements in the accuracy and, sensitivity of liquid phase assays: in US patent 5 605 806, S. Tanaka and H. Tamura proposed a LAL
and an antibody to ne~~traiize the false positive results due to (1 -> 3)-Q-glucan.
Shigenori et a! proposed the use of factor G activation to resolve the same problem (US patent 5.641,643?. Besides the liquid phase reaction systems, a method for lysate immobilization tc~ wells of a polystyrene microplate has been published. In US patent 5,550,30, Tanaka disclosed a quantitative kit for endotoxin determination which comprises an insoluble carrier vn which is immobilized an endotoxin-sensitive factor derived from a limulus amoebocyte which specifically reacts with endotoxin Yr'rthout reacting with 13-glucan. The test system involves the indication of endotoxi~ when colouring occurs in the liquid phase.
Quick and simple testing for endotoxin is important in a number of circumstances, including when changilg the dialysis machine, or monitoring tap water. It is also desirable to determine endotoxin levels of the fluids in a laboratory-setting.
The SUBSTITUTE SHEET (RULE 26) 1a-5tr-~~d lb: ~~ f9H ~ hirb 2~ 51~u1Kt nee rrx~e~ eiemi r. no.,~r~

w0 99I533Z2 PCTIGB99101099 degree of contaminati~~n of water and dialysate fluids falls into several categories, but in all cases it is de~.irable to monitor endotoxin present in the fluid on a frequent -' basis. A simple and quick method for determining qualitatively endotoxin in a-test solution is thus much sought in the art.
The present mventio.~ provides an analytical test strip for the detection of endotoxin in aqueous .solutions in which the strip is wetted at the bottom with the sample. After a certain period of time, until the sample flows from the bottom to the top, an indicator is added at the top, to develop a red colour which is indicative for the presence or the absence of endotoxin in the sample.
Using a technique of a solid phase chromogenic substrate assay, the present invention involves an improvement to a quick test strip for the detection of endotoxin. The test strip provides a dry analytical element for endotoxin which comprises an absorbent carrier divided in four portions impregnated with: 1 ).
a reagent system of lim~:lus factors; 2) synthetic chromogenic substrate derivatized with' p-nitroaniline; .3) .3 buffer system containing chloride acid and sodium nitrite;
41 a buffer system containing chloride acid and ammonium. The test afro includes a solution containing 111-naphtylethylenediamine which .is added at the top of the _ test trip to develop a coloration by coupling the derivatized p-NA- to ~N1-napthylethylenediamine as positive results.
T'he present invention provides apparatus and method as,defined in the claims, in particular an analysis method comprising applying a aqueous sample solution to the bottom of the described dry analytical element to react with endotoxin, and determining coloratioi on the top of the dry element by coupling N1-napthylethylenediamine. The present invention also provides an endotoxin kit using - the above described dry analytical element.
A further object of this; invention is to provide a method for preparing the above mentioned dry analytical element andlor the portions of the dry analytical element for preparing the above described endotoxin test strip.
SUBSTITUTl; SHEET (RULE 26) 18-SEP-2000 16~23 MHTHYS 8 SQUIRE 020 ?830 0001 P.0?/30 The method involved in the invention is a direct solid phase chromogenic caiorimetrical detection. Four supports are arranged successively in the same alignment to achieve << flow communi6ation with each other. The supports are ' -mounted in a closed arid pyrogen free casting module, The test strip comprises a solid support having four portions (at least three portions) being in flow communication with ~:ach other whereby reaction products can flow from one portion to the next. The solid support is preferably shaped in the form of strip, with the first, second, third and fourth portions being arranged on the strip in the same plane. The size:; of the portion may be the same or different. The portions are manufactured to absorb the different chemicals and dried, and attached on the strip in a way that flow communication occurs from one to the next.
The test strip would be submerged with the sample at the bottom to wet the first portion and allow liquid to flow from bottom to the top of the test strip. The sample solution woulc start to flow by capillary action from one portion to the next higher portion. Thus, the reactants occurring in each portion would be.transported by capillary flow to th~: last portion to develop a red coloration as a positive result.
The first portion contains a solid support and a (imulus -amaebocyte lysate or substances containirn3 endotoxin sensitive factors which react with endotoxin to produce coagulin. ~he method of the immobilization of the lysate or of the endotoxin sensitive f~sctor to the solid support are: 1 ) absorption: 2) adsorption by ionic forces orland hydrophobic interaction, 3y covalent binding. The procedures for binding the lysate in the solid support are generally known the art. The lysate may be the commercial available limulus amoebocyte fysate such as Limulus Polyphemus, Tchyp~eus iridendafus, Tachypleus gigas and Carcinoscorpius ~otundicauda. Preferably a lysate without Factor G may used in order to avoid a positive false-reaction with i~-31-f3-WGlucan contained in the sample or in the solid support. A purified form of a mixture containing factors C. B and prociotting enzymes, which react with- endotoxin to produce coagulin may also be used.
Preferably a lysate preparation known in the art without Factor G which does.not react with (1-3Lf3-D-Gtucan may also be used. The amount and biological activity SUBSTITUTE SHEEt (RUSE 25) 18-SEP-2000 16:23 MRTHYS & 5QU1RE bid 'ftiib bbdl h'.btii,5b of endotoxin reagents, and the material and size of the solid support determine the sensitivity of the test strip. Upon wetting of the solid support with the sample, sample.~houid react with immobilized lysate or substances containing endotoxin factors to activate Factor and clotting enzymes. Depending upon the presence of endotoxin in the samples, endotoxin activates the bound lysate in the following reaction steps:
t1 f Endatoxin -> activated Factor C
t21 activated Factor C -~ Factor B -> activated Factor B
(3) activated Factor 8 -> Praclotting enzyme The clotting enzyme produced through the cascade reaction by the action of activated Factor C or proclotting enzymes is capable of hydrolysing coagu(in or an amide linkage of a synthetic peptide substrate at the specific sites intermediate between Arg and GIy ~~r intermediates between Arg and Thr.
The solid support which is- employed in this test strip is one which is capable of absorbing endotoxin i~rom the sample. When wetted, the sample containing endotoxin reacts with reagents in the first portion and the reaction products are transported by flow to the dry region of the first support and thus to the second portion of the test strip. In addition, the solid support is one which is capable of absorbing both sample: and binder. In order to achieve a flow communication between the portion, it is preferable to use an hydrophillic polymers solid support.
Examples of suitable supports are chromatographic papers, nitrocellulose, dextran and glass fibres. Preverabiy, chromatographic hydrophobic polymers are used though if using chrom:~tography papers, it is important to use reagents which do not react with -(3-gluca~, as described for example in US patent 5,550,030.
The second portion contains a solid support and a synthetic substrate. A
typical substrate to be immobi ized in the second portion is t-butaxycarbanyl-Ieucyl~glycyl-SUBSTITUTE SHEET (RULE Z5j ia-~r-~~d ib: ~4 MH I HY5 XWhIU 1 Kt. l~~b ~re,se dm r. ey~,s~o WU 99153322 , PCTIGB99101099 arginine-paranitroanilide (8oc-Leu-Gly-Arg-pNA) to release paranitroani(ide.
Usable synthetic peptides with a known detectable group are those described in EP-A-0000063, EP-A-00113112, W079/00602, W082/02382 and US 4,188,264.
However, synthetic p~;ptide substrates for activated Factor C as well as synthetic peptide substrates for activated clotting enzymes in which a carboxyl group of the C-terminated argininE~ -is substituted with the colour-developing residue p-nitroaniiine, p-(N,N-di~ahylamine)aniline, p-(N-ethyl-N-f~-hydroxyethyl) aniline can also be used. Possible methods of immobilization of the chromogenic substrate to the solid support ors: 1 ) absorption; 2) adsorption by ionic forces or/and hydrophobic interacti~3n, and 3) covalent binding. Preferably, the support is absorbed with the substrate. The solid support is typically made with the same material as the first s~:pport and it is one which is capable of absorbing the liquid and reactants flowing from the first support, and which when wetted is this way, provides for flow and analyte by capillary attraction from the first portion, and through the second portion into the third portion. Upon contact with the liquid and reactants flowing from the first support, solution should react with immobilized chromogenic substrate. Like the first portion, examples of suitable supports are chromatographic papers, nitrocellulose, dextran and glass fibres. Preferably, chromatographic papers are used. The s4lid support absorbed with the ohromogenic substratE is one which is capable o~absorbing reactants flowing from the first support. When wetted, the so-called reactants are capable of reacting with the second portic,n and the reactants with the new reaction products being transported to the dry regions and thus to the third portion of the test strip. The solid , support is so manufactured (with attention to the amount of absorbed synthetic chromogenic substrate, size of the portion, material of the solid support) that activated clotting ~:nzyme andlor factor B flowing from the lower portion reacts with substrate in the second portion and the chromophore p-nitroaniline is cleaved.
The cleaved p-nitroaniline is then transported to the next portion.
The third portion contains a solid support and a buffer containing 1 N NCI and 0.1 % (wlv) sodium nit~ite. Preferably, to make the support; it is impregnated with the buffer system, dried and is made with the same material as the second support.
SUBSTiME SHEET (RULE ?.~) 11i-5th'-~I~b 1b~~4 IhHIHYS ZS SL,lUIKt 1~~'t~ '~ti,5l~ l:)b1~1 t'.11~~,310 WO 99153322 PC'T'IGB99101099 .7.
When dried, the~solid support is also one which is capable of absorbing the liquid and the chromophore p-nitroaniline flowing from the second support, and which when wetted is this may, provides for flow from the second portion, and through the third portion into the fourth portion.
The fourth portion contains a solid support and a buffer containing N HCI
containing 0.5°6 ammonium. Preferably, to make the support, it is impregnated with the buffer system, end dried. When absorbed with the buffer system and dried, the solid support is also one which is capable of absorbing the liquid and the chromaphore p-nitroa~iline flowing from the third support, and which when wetted is this way, provides for flow from the third portion, and through the dried region, The third and fourth portions are those through which when the flowing free p-nittoaniiine released by the action of enzymes is derivatized to its diazanium salt, typically formed in th,: fourth portion.
The fifth portion is a neutral portion in which a drop of 0.05 % N 1-naphtylethylenediamine in 40-50% (v/vf is added to form a highly visible red colour by cQUpling of the de-ivatized p-NA to N1-napthylethylenediamine.
The test strip described in this invention can suitably be prepared from any matrix material through whi~:h an aqueous solution can flow by capillarity. Suitable materials for chromatographic strips are paper, nitrocellulose and hydrophillic polymers. because of the presence of f3-glucan in cellulosic material, paper is riot usually suitable without special treatment as it induces false positive results. In this invention, it is desirable to use hydrophillie polymers which allow vertical capillary flow excluding a bibulous lateral flow such as polyethylene sheet material.
,_ There now foNows description of specific embodiments of the present invention, illustrated by drawings in which:-Fig. 1 shows a schematic representation of a capillary test strip;
SUBSTITUTE SHEET (RULE 26~

113-5th'-~t~b lb~ ~5 MH 1 HY5 X~ 5L,lUlKt 1~~4~ 'fti.5d dbl~l h'. l lii4~

wo 99rs33zz , rcrrc B99ro ~ 099 -e-Fig. 2 shows .3 schematic representation of a paper test strip;
Fig. 3 shows mode of operation of a test strip;
Fig. 4 shows variation of substrate sensitivity and resulting lysate activity;
and Fig. 5 shows ~~ quantitative test strip.
~xarnple 1: capillary test strip As illustrated in figure 1, a glass howl capillary glass with a flat side, an internal dimension of 0.25 em and an external dimension of 0.2$ cm and a length of 4 cm has been used as the casting module. For the bottom of the capillary there is a cap which is used as the ,;ample reservoir, whereas a second cap closes the top of the capillary and permits entry of chemicals for the colour reaction. The module is constructed in a w.~y that it remains pyrogen free. The howl module is successively filled wi~:h dried hydrophillic porous spherical material (200-500 ~nl, The hyijrophillic por4~.~s polymer is in separate portions, impregnated as follows:
Portion 1: hydrophillic polymeric powder was incubated under pyrogen free conditions in 0.5 IU/ml (1 glml) of limulus amoebocyte lysate (Charles River-Suizfel Germany) until saturated absorption of the liquid was reached. After drying, the module has been filled to reach a height of 1 cm. 0.1 cm has then been filled with neutral polymeric povrder.
Portion 2; 10 ~rmo) of chromogemic substrate (t-butoxycarbonyl-ieucyl-glycyl-arginme-paranitroanili~e) for endoxin (Pefachrome LAL Code.NR 11179-01 ISO
9001-1N29001 Penta~pharm AG BASEL CH) was diluted in 6.6 ml pyrogen free .
water. 1 g of hydrophillic polymeric material was also incubated with 1 m1 until saturated absorption was reached. After drying the module has been filled to reach a height of 0.5 cm. C1.1 cm has then been filled with neutral polymeric powder.
SUBSTITUTE SHEET (RULE 2B) 18-SEP-2000 16~25 MATHYS & SQUIRE 020 7830 0001 P.12i30 WO 99!53322 PCTIGB99I01099 Between portions 2 ;end 3: Tris-HC) is mixed with polymeric powder to obtain a concentration of 0Ø5 mmol/I and inserted between portions 2 and 3 with a height of O.S cm. 0.1 cm has been filled ~evith neutral polymeric powder.
' ' Portion 3: Polymeric powder was submerged in a solution of 1 N HCI
containing 0.1 % (w/v) sodium nitrite, and dried. A quantity sufficient for 0.5 cm has been inserted into the module. 0.9 cm has been filled with neutral polymeric powder.
Portion 4: 1 cm of polymeric powder was submerged with in solution of 1 N HCl containing 0.5 °~ ih~'Ivl ammonium sulfate, dried and has been filled into the module. 0.1 cm has been filled with neutral polymeric powder.
Portion 5 : 2.5 mg of N1-naphthlethylenediamine in mixed with 0.5 cm polymeric material.
Example 2: paper tes-: strip ' The strip can prepared from any matrix material through which the test fluid can vertically flow by capillarity; as illustrated in figure 2, a polystyrene dipstick was constructed to be fitted in a sterile battle. The active surface of the test strip was 0.5 cm x 4.2 cm, separated every 0.5 cm between the first portion and the third portion with 0.5 cm x 0.2cm dry Sephadex. The active surface between the sephadex strip was dated with Scotch adhesive transfer tape , 969 13M, USA, 5x144) Portion 9: consisted cf 0.5cm x 0.5 cm ultra high molecular weight polyethylene sheet material tPorex Technologies) which was incubated for 10 min under pyrogen free conditions in 0.5 IUImI ( 1 glmll of limuius amoebocyte lysate (Charles River-Sulxfel Germany). At;er drying, it was applied to the bottom et the test strip, A
i neutral 0.5 cm x 0.7 :m-portion was added above the neutral sephadex.
Portion 2: consisted of 0.5cm x 0.5 cm ultra high molecular weight polyethylene ' SUBSTITUTE SHEET (RULE 26) 18-SEP-2000 16~26 MRTHYS 8~ SQUIRE 020 7830 0001 P.13i30 ' ~~ CA 02327169 2000-09-29 wo 99is33zZ
PCT~GS99lot 099 .10-sheet material tPorex Technologies) which was spotted with 1.5 ,umollml of Chrvmogenic substrate (t-butaxycarbonyl-leucyl-glycyl-arginine-pa-ranitroanilide) for ~ndoxin (Pefachrome I.AL Code NR 11179-O1 ISQ 9001-7 N29001 Pentapharm AG
BASEL CH). The strip was applied lust above the neutral sephadex portion. , -Between portions 2 and 3: consisted of 0.5em x 0.5 cm sephadex and Tris-HC( at a concentration of 0.025 mmolh.
portion 3: consisted of a 0.5 cm x 0.5 em strip of filter paper (Schleicher &
Shuel 23 SL) which was submerged with solution of 1 N HCl containing 0.1 °~
(w!v) sodium nitrite, dried and applied above the neutral sephadex portion.
Portion 4: consisted of a 0.5 cmx 0.5 cm strip of filter paper (Sehleicher &
Shue) 23 SL) which was submerged with in solution of 1 N HCI captaining 0.5 % (Wlv) ammonium sulfate, dried and applied above the third portion.
Portion 5 : consisted of a 0.5 cmx 0.5 cm strip of filter paper (Schleicher &
Shuel 23 SL) applied above the fourth portion.
For both examples :he assay is carried out as follows:
1 ) add the simple to the first portion of the test strip or immerse the first portion in the sample (example 2) or fill the reservoir with the sample (example 1 )-2) heat the test strip to 37 °C device to activate the reaction;
3) allow sufficient time (such as 4 min) for the sample to flow from the bottom to tt-;e top:
4) dry the test strip by removing the sample reservoir from the bottom and opening the bottom of the casting; and 5) for colour development, a drop of 47.5% ethanol is added, coloration develops after drying in air.
The chemical reactions involved in each portion are described in Figure 3. In __ ~ .........w lot tl ~ '~i~

18-5EP-2000 16~26 MRTHYS & Sf~UIRE 020 7830 0001 P.14~30 WO 99/53322 PGTlGB99101099 portion 1, depending upon the presence of endotoxin in the samples, clotting enzyme is produced through the cascade reaction by the action of activated Factor C or prociotting enzymes. In portion 3 after the papillary flow through the chromagenic substra~:e and in the presence of Tris-HCI, the activated clotting enzyme andlor factor S flowing from the lower portion cleaves p-nitroaniline.
The cleaved p-nitraanitine being transported to the third and fourth portion and derivatized to its diazonium salt. In the fifth portion, the diazonium salt is coupled to N1-napthylethylenediamine to form a diazoamino of a red colour.
The assay can be performed with different sensitivities, according to the grade of contamination to be analyzed. (n the special application to test solutions used in hemadialysis therapy and according to Pharmacopoeia prescriptions, several test strips have been elaborated to read the minimal acceptable concentration of endotoxin in aqueous solution (Table 1 ).
Table 1 AppGoatians SubstitutionitemodialysisDialysateWater for on-solution water solutionfine HDF
for Hamvdiafiiuatlon Lowest LPS concentration 'n l:Ulml 0.05 0.25 0.5 t In respect to the sensitivity of the test, numerous modification can be performed, such as by varying the: titration of the LAL-concentration and the matrix material used in the first portion. By the application of high molecular weight polyethylene sheet material (Pore;; Technologies) and using several titrations of limulus amoebocyte lysate varying from 0.1 to 0.5 lUlml and several matrices, for examples 1 and 2, it is possible to prepare 3 classes of lysate concentrations. The method used to prepa~e the desired lysate concentration is first based on a liquid .I chramagenic subsuate assay in a microplate according to the LAL-test Endochrome-K~'"' (US. License No ~ 073) except that the I.AL-concentration is not related to the protocol. Figure 4 illustrates the resulting absorbance due to the SUBS'ffTUTE SHEET (RULE 26) 18-SEP-2000 16=2? MRTHYS 8 S(~UIRE 020 9830 0001 P.15i30 WO 99/53322 PC"TIG 899/0!099 variation of the f_A!_ which allow 4 classes of test-strips. Applied to the test-strip of example 2, it is pv~sible to prepare a test-strip especially for the detection of endotoxin concentration. in diaiysate-solution, for which the acceptable firnit is ~-prescribed to be beiour a.5 EU/m!. Detection spots for this prepared test strip are ihustrated in Figure 5.
suesTtn~ sHEF-r (pum zs) lti-5th'-~lJdd 1b ~ ~'f num t a a ~u a r~~ ~~... . ........ ....... . .

WO 99/S33ZZ PCTfG899101099 References:
" 7 J. Levin and F.3. Bang Bult. Johns Hopkins Hospital, 115, 265.274 (1964) 2 Progress in Clinical and Biological Research, Volume 93; 'Endotoxin and their petection with the Limulus Amoebocyte Lysate Test"; edited by Stanly W. Watson, Jack Levin and Thomas J. Novitsky (1982); pages 7-24 3 lwanaga et al. -temostasis, Z, 1$3-199 (18781 4 J. Clin Microbio. 17, 1050-1053 11983) Related Application Data:
1 Solid phase chromatographic immuno assay- Rosenstein-US patent 5,591,fi45 (Jar4 7, 1997) 2 Method for the detection of protein urine- Cahil et ai: US patent 5,593,895 (Jan 14, 1997) 3 Reagent for en~otoxin-specific assay- Tanak et al, US patent 5,550,030 (Aug 27 1996) 4 Test strip for blood glucose testing- Kelvin J. Philipps- US patent 5,556,761 tSep 17, 1996) - 5 Quantitative de°_ection of analytes on immunochromatographic strip-Ronald G Sommer- US patent 5,569,608 (Oct 29, 1996) 6 Horses Crab arroebocyte lysate factor G activation inhibitor- Tanaka S.- US
patent 5,641,63 (Jun, 24, 1997) SUBS'1'1TUTE SHEET (RULE Z6) 18-SEP-2000 16~27 MRTHYS & SQUIRE 020 7830 0001 P.17/30 WO 99153322 . PC'1'IGB99101099 7 Reagent for assaying endotoxin. Tanak S- US patent 5,605.806 (Feb 25, 1997) 8 Test articles fvr performing dry reagent prothrombin time assays Stephen E.
Zweig et al. US patent 5,418,141 (May 23, 1995) 9 Composite celil:lose nitrate membrane on polyester support- Beer et a!- US
patent 5,628,9130 (May 13, 1997) One step-test d~:vice. Philip W. Sayies. US patent 5,591,401 Clan 7, 1997) SU8ST1TUTE SHEET (RULE 26)

Claims

-15-7. Solid phase apparatus, for detection of endotoxin in a liquid sample using-reagents located within solid support material, comprising the reagents:
endotoxin sensitive reagent; and buffer components;
wherein whet a liquid sample containing endotoxin is applied to the apparatus the endotoxin sensitive reagent reacts with the endotoxin to form at least one product, and following contact of the at least one product with buffer components an endotoxin indicator is formed.
2. Solid phase apparatus according to Claim 9 further comprising a colour developer, which reads with the endotoxin indicator to form a coloured product.
3. Solid phase apparatus according to Claim 1 or 2 wherein the reagents are differentially located within portions of the solid support material, and wherein the apparatus comprises:
an application portion to receive a liquid sample, and containing endotoxin sensitive reagents comprising endotoxin sensitive factor aid a first chromogenic substrate, and being in communication with a buffer portion;
the buffer portion containing buffer components, end being in communication with an indicator portion; and the indicator portion optionally containing a colour developer or being adapted to receive application of a colour developer by a user wherein in use when a liquid sample containing endotoxin is applied to the application portion, endotoxin reacts with endotoxin sensitive factor to form a product which in turn reacts with the first chromogenic substrate to form a second chromogenic substrate, and contact of the second chromogenic substrate with buffet components forms an endotoxin indicator.

4. Solid phase apparatus according to Claim 3 wherein the application portion comprises:
a first portion containing an endotoxin sensitive factor, in communication with a second portion containing a first chromogenic substrate, in communication with the buffer portion.
5. Solid phase apparatus according to Claim 3 or 4 wherein the buffer portion comprises:
a third portion containing first buffer components, in communication with a fourth portion containing second buffer components, in communication with the indicator portion, whereby in use contact of the second chromogenic substrate with the first and then the second buffer components results in formation of the endotoxin indicator.
6. Solid phase apparatus according to Claim 3, 4 or 5 wherein the indicator portion is substantially free of solute capable of altering pH.
7. Solid phase apparatus according to any of Claims 1-6 for the detection of endotoxin in a liquid sample comprising a solid support in the form of a test dipstick, a flat sheet or a cylindrical capillary tube wherein said solid support is selected from chromatographic papers, silica nitrocellulose, hydrophillic polymer, dextran, and glass fibres.
8. Solid phase apparatus according to any previous claim in the form of a said test strip which comprises several portions made with hydrophillic matrix from which .beta.-glucans have previously been extracted with a solvent system;
9. Solid phase apparatus according to Claim 8 wherein the test strip is constructed in a flat sheet form, said portions are constructed in a plane form to permit capillary flow, between respective portions.

10. Solid phase apparatus according to any previous claim wherein the solid support material is mounted in a closed and pyrogen free transparent casting module to achieve pyrogen free manipulation.
11. Solid phase apparatus according to Claim 10, wherein the said transparent casting module can be opened at the bottom to permit contact with the sample or can be placed in a sample reservoir and can be opened at the top to permit contact with chemical reactants.
12. Solid phase apparatus according to any previous claim wherein the colour developer is N1-napthylethylenediamine.
13. Solid phase apparatus according to any previous claim wherein the endotoxin sensitive factor a limulus amoebocyte lysate or other factors which react with endotoxin to produce coagulin.
74. Solid phase apparatus according to any previous claim wherein the first chromogenic substrata is t-butoxycarbonyl-leucyl-glycyl-arginine-paranitroanilide (Boc-Leu-Gly-Arg-pNA) and paranitroanilide is the second chromogenic substrate.
15. Solid phase apparatus according to Claim 14, wherein the endotoxin indicator is p-nitroaniline.
16. Solid phase apparatus according to any previous claim wherein the buffer components contain hydrochloride and sodium nitrite ions.
17. Solid phase apparatus according to Claim 16, wherein the buffer components contain hydrochloride and ammonium ions.
18. Solid phase apparatus according to any previous claim wherein the indicator portion is a neutral portion.

19. Solid phase apparatus according to any previous claim wherein contact on the second chromogenic substrate with buffer components converts it to a diazonium salt.
20. Solid phase apparatus according to Claim 19, wherein which p-nitroaniline is derivatized to N1-napthylethylenediamine.
21. Solid phase apparatus according to Claim 20, wherein the indicator portion is changed to a highly visible red colour when a drop of a solution containing N1-naphtylethylenediamine is added to form a diazoamino of a highly visible red colour.
22. Solid phase apparatus according to Claim 20, wherein the indicator portion contains a solid support and N1-naphtylethylenediamine to form a diazoamino of a highly visible red colour.
23. A method of assaying for the presence of endotoxin in a liquid sample, comprising combining a test amount of the sample with reagents in a first region of solid phase support materia to form at least one product:
allowing the one or more products to flow through a second region of solid support material containing buffer components thereby to convert the at least one product into endotoxin indicator; and testing for the presence of the endotoxin indicator.
24. A method according to Claim 23 wherein endotoxin indicator is coloured.
25. A method according to Claim 23 further comprising reacting, in a region of solid support material, the endotoxin indicator with a colour developer to form a coloured product.
26. A method according to any of Claims 23 to 25 comprising heating the support material to activate the reagents.

27. A method according to any of Claims 23 to 26 comprising measuring the intensity of the coloration of the endotoxin indicator to determine concentration of endotoxin.
28. A kit for testing for the presence of endotoxin in a liquid sample, comprising at least two solid phase apparatus according to any of claims 1 to 22, wherein the at least two apparatus have different sensitivities to endotoxin.
29. A kit according to Claim 28 comprising a plurality of solid phase apparatus of different sensitivities, to endotoxin for quantitative determination of endotoxin in a liquid sample.
30. Use of solid phase material containing buffer components in manufacture of solid phase apparatus or testing for the presence of endotoxin in a liquid sample.
37. Use of solid phase material containing endotoxin sensitive reagent in manufacture of solid phase apparatus for testing for the presence of endotoxin in a liquid sample.
CA002327169A 1998-04-09 1999-04-09 Solid phase test for endotoxin Abandoned CA2327169A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9807814.0A GB9807814D0 (en) 1998-04-09 1998-04-09 Solid phase test for endoxin
GB9807814.0 1998-04-09
PCT/GB1999/001099 WO1999053322A1 (en) 1998-04-09 1999-04-09 Solid phase test for endotoxin

Publications (1)

Publication Number Publication Date
CA2327169A1 true CA2327169A1 (en) 1999-10-21

Family

ID=10830245

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002327169A Abandoned CA2327169A1 (en) 1998-04-09 1999-04-09 Solid phase test for endotoxin

Country Status (5)

Country Link
EP (1) EP1042672A1 (en)
AU (1) AU3432899A (en)
CA (1) CA2327169A1 (en)
GB (1) GB9807814D0 (en)
WO (1) WO1999053322A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003038433A1 (en) * 2001-10-29 2003-05-08 Arkray, Inc. Test apparatus
ATE452986T1 (en) 2003-03-17 2010-01-15 Charles River Lab Inc METHODS AND COMPOSITIONS FOR DETECTING MICROBIAL CONTAMINANTS
JP2008522640A (en) 2004-12-02 2008-07-03 チャールズ リバー ラボラトリーズ, インコーポレイテッド Methods and compositions for detection and / or quantification of Gram positive bacteria contaminants
EP1836492B1 (en) 2005-01-13 2008-12-31 Charles River Laboratories, Inc. Method for classifying a microorganism in a biological sample
US20130078665A1 (en) * 2012-07-18 2013-03-28 Deepika Bodapati Test strip, a test kit and a method for detection of endotoxin in food

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717658A (en) * 1985-12-03 1988-01-05 Miles Inc. Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL)
GB8624253D0 (en) * 1986-10-09 1986-11-12 Harvey W Endotoxin assay
CA1303983C (en) * 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
DK255887D0 (en) * 1987-05-20 1987-05-20 Claus Koch IMMUNOASSAY
US5198339A (en) * 1990-07-13 1993-03-30 Board Of Regents, The University Of Texas System Method for detection of gram-negative bacterial lipopolysaccharides in biological fluids
JP3322700B2 (en) * 1992-09-14 2002-09-09 生化学工業株式会社 Endotoxin-specific measuring agent for solid-phase reaction
US5773306A (en) * 1996-05-24 1998-06-30 Trustees Of The University Of Pennsylvania Methods and kits for the detection of endotoxin

Also Published As

Publication number Publication date
WO1999053322A1 (en) 1999-10-21
GB9807814D0 (en) 1998-06-10
EP1042672A1 (en) 2000-10-11
AU3432899A (en) 1999-11-01

Similar Documents

Publication Publication Date Title
EP0378391B1 (en) Threshold ligand-receptor assay
AU617090B2 (en) Qualitative immunochromatographic method and device
US7312028B2 (en) Highly cost-effective analytical device for performing immunoassays with ultra high sensitivity
AU637399B2 (en) Improved solid assay support systems
US20040018576A1 (en) Bence Jones protein testing cassette
EP2284538B1 (en) Biosensor
EP0447154A2 (en) Device for ligand-receptor methods
EP1111386A3 (en) Test strip for the assay of an analyte in a liquid sample
RU2006135394A (en) SYSTEM OF THE MEASURING DEVICE OF THE LEVEL OF ANALYZED SUBSTANCES IN BIOLOGICAL LIQUIDS AND CARTRIDGES FOR PERFORMANCE OF THE COMBINED GENERAL CHEMICAL AND SPECIFIC BINDING ANALYSIS
JPH01299464A (en) Solid phase analyzer
AU610412B2 (en) Composition and method of assaying liquids for specific gravity
JPS63269056A (en) Immunity testing apparatus
JPH04290961A (en) Device for effecting rapid and easy manual assay
CN110687286A (en) Latex enhanced immunoturbidimetry kit
EP2839288B1 (en) An enzyme detection device
JPH0750114B2 (en) Analysis method using immunoassay instrument
EP1141714A1 (en) Dipstick for carbohydrate-free transferrin assay
CA2286414A1 (en) Non-separation heterogenous assay for biological substance
US20020160428A1 (en) Quantitative non-instrumental immunoassay and device using coloured particles
CN104849264B (en) A kind of chemiluminescence immunoassay strip and preparation method thereof
US4786606A (en) Solid phase system for ligand assay
CA2327169A1 (en) Solid phase test for endotoxin
US6228658B1 (en) Method of using a test strip for the immunochemical detection of substances
CA2251444A1 (en) Process and apparatus for detecting substances associated with dust
US8632981B2 (en) Method for a rapid test

Legal Events

Date Code Title Description
FZDE Discontinued